U21-S01. In vivo Efficay Assays of drugs, nanomedicines, biomaterials and others (Remote) OUTSTANDING
Preclinical efficacy assays in
Preclinical evaluation of efficacy according to European Directives; In vivo models for the pilot feasibility; Biocompatibility. Animal models of human diseases: diabetes, obesity, hypercholesterolemia, hypertriglyceridemia, acute and chronic myocardial infarction, prostatic hyperplasia, ulcers, pleural adhesions, constrictive pericarditis, and abdominal aortic aneurysm among other; Animal species: rodents, rabbits, dogs, cats, pigs and sheep. Creation of different pathologies: oncological, cardiovascular, ophthalmology, transplants, assisted reproduction, cell therapy, etc.
Efficacy and safety of medical devices and biomaterials. Efficacy and toxicity studies of new molecules and pharmaceutical forms.
Murine model embryo tranfers; intracytoplasmic microinjection, oocyte vitrification, measurement and analysis of samples of Natural Killer cells (NK), seminogram and semen studies.